Capital Performance Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Capital Performance Advisors's JNJ Position: Q2 2026 in Review
Capital Performance Advisors reduced its Johnson & Johnson (JNJ) stake by 38% in Q2 2026, selling an estimated $888K and leaving 6,284 shares worth $1.6M. The position accounts for 0.1% of the portfolio, ranked #91.
Capital Performance Advisors first reported a position in JNJ in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.47M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Capital Performance Advisors held 6,284 shares of Johnson & Johnson worth $1.6M as of Q2 2026.
- Capital Performance Advisors sold 3,811 Johnson & Johnson shares in Q2 2026, an estimated $888K.
- Johnson & Johnson made up 0.1% of Capital Performance Advisors's portfolio in Q2 2026, its #91 holding.
- Capital Performance Advisors first reported a position in Johnson & Johnson in Q3 2024 and has held it in 7 quarters since.
- Capital Performance Advisors's Johnson & Johnson position peaked at $2.47M in Q1 2026.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Capital Performance Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.